IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

Use an existing password
Company dossier

Dr. Lal Path Labs

NSE:LALPATHLAB · ISIN INE600L01024

Close
₹1,882.5
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Dr. Lal Path Labs

Filings

Preserved evidence

Primary-source filing timeline

40 recent events
Change in Director(s) - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing
Shareholders meeting - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing
Shareholders meeting - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Dr. Lal Path Labs Ltd.NSE · conference call · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · audio
Source filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Press Release - Dr. Lal Path Labs Ltd.NSE · financial results · pdf
Source filing
Investor Presentation - Dr. Lal Path Labs Ltd.NSE · investor presentation · pdf
Source filing
Outcome of Board Meeting - Dr. Lal Path Labs Ltd.NSE · financial results · pdf
Source filing
ESOP/ESOS/ESPS - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Record Date - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-AcquisitionBSE · exchange filing · pdf
Source filing
Outcome of Board Meeting - Dr. Lal Path Labs Ltd.NSE · financial results · pdf
Source filing
Dividend - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Dividend UpdatesBSE · corporate action · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Board Meeting Outcome for Outcome Of Board Meeting - July 24, 2026BSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing
General Updates - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Grant Of Stock OptionsBSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - The Record Date For The Purpose Of Payment Of Interim Dividend Shall Be July 30, 2026BSE · corporate action · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Dr. Lal Path Labs Ltd.NSE · conference call · pdf
Archived filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Received An Appellate Order From Income Tax DepartmentBSE · exchange filing · pdf
Archived filing
Dr. Lal PathLabs Ltd - 539524 - Corporate Action-Board to consider DividendBSE · corporate action · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Update on board meetingBSE · exchange filing · pdf
Source filing
General Updates - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Archived filing
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Updates - Dr. Lal Path Labs Ltd.NSE · exchange filing · pdf
Source filing
Updates - Dr. Lal Path Labs Ltd.NSE · annual report · pdf
Archived filing